Literature DB >> 2450942

Effects of human prostatic mitogens on rat bone cells and fibroblasts.

M Koutsilieris1, S A Rabbani, D Goltzman.   

Abstract

We examined several characteristics of the mitogenic activity of extracts of human prostatic adenocarcinoma and human benign prostatic hyperplasia in fetal rat calvarial cells, cloned rat osteosarcoma cells and rat skin fibroblasts. Prostatic moieties produced maximal stimulation of [3H]thymidine incorporation at 24 h, were mitogenic in the absence or presence of various concentrations of serum, and were active in calvarial cells enriched with osteoblasts, skin fibroblasts and the cloned rat osteosarcoma cell line UMR 108. The known growth-promoting agents insulin, insulin-like growth factor, fibroblast growth factor, platelet-derived growth factor, epidermal growth factor, interleukin-1 alpha and beta and transforming growth factor beta were also mitogenic in the indicator systems employed; however, maximally stimulating effects of these peptides in cells of the osteoblast phenotype were further enhanced with prostatic material. Prostatic activity was acid-stable and could be enriched with respect to osteoblast stimulation by hydrophobic and carboxymethyl ion-exchange chromatography. The results demonstrate the presence of potent mitogenic activity in hyperplastic and malignant prostatic tissue which appears to include unique osteoblast-stimulating activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2450942     DOI: 10.1677/joe.0.1150447

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  9 in total

Review 1.  Morphologic and regulatory aspects of prostatic function.

Authors:  G Aumüller
Journal:  Anat Embryol (Berl)       Date:  1989

2.  Oncogenic Role of the Ec Peptide of the IGF-1Ec Isoform in Prostate Cancer.

Authors:  Athanasios Armakolas; Maria Kaparelou; Andreas Dimakakos; Efstathia Papageorgiou; Nikolaos Armakolas; Athanasios Antonopoulos; Constantina Petraki; Maria Lekarakou; Pavlos Lelovas; Martha Stathaki; Constantinos Psarros; Ismene Donta; Panos S Galanos; Paul Msaouel; Vassilis G Gorgoulis; Michael Koutsilieris
Journal:  Mol Med       Date:  2015-01-06       Impact factor: 6.354

3.  Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton.

Authors:  C Reyes-Moreno; M Koutsilieris
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

4.  Insulinlike growth factor-1Ec (MGF) expression in eutopic and ectopic endometrium: characterization of the MGF E-peptide actions in vitro.

Authors:  Dimitrios S Milingos; Anastassios Philippou; Athanassios Armakolas; Efstathia Papageorgiou; Antigone Sourla; Athanassios Protopapas; Anthi Liapi; Aris Antsaklis; Minas Mastrominas; Michael Koutsilieris
Journal:  Mol Med       Date:  2010-09-14       Impact factor: 6.354

5.  Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells.

Authors:  Efstathia Papageorgiou; Nea Pitulis; Menelaos Manoussakis; Peter Lembessis; Michael Koutsilieris
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

6.  Soluble factors produced by PC-3 prostate cells decrease collagen content and mineralisation rate in fetal rat osteoblasts in culture.

Authors:  J F Santibáñez; S Silva; J Martínez
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

7.  Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies.

Authors:  P Autzen; C N Robson; A Bjartell; A J Malcolm; M I Johnson; D E Neal; F C Hamdy
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

8.  Prognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate Cancer.

Authors:  Kyo Chul Koo; Sang Un Park; Ki Hong Kim; Koon Ho Rha; Sung Joon Hong; Seung Choul Yang; Byung Ha Chung
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

Review 9.  Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.

Authors:  Niaz Mahmood; Catalin Mihalcioiu; Shafaat A Rabbani
Journal:  Front Oncol       Date:  2018-02-12       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.